Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
2 Best Biotech Stocks to Buy in July
10:00am, Thursday, 06'th Jul 2023
Johnson & Johnson and Merck both sell numerous popular medicines. Both also have encouraging pipelines that should lead to more products.
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
09:15am, Monday, 03'rd Jul 2023
Each has a blockbuster therapy that is likely facing declining sales. But both companies' pipelines have more than 100 programs.
The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023
12:39pm, Friday, 30'th Jun 2023
Pharmaceutical stocks have not shared in this year's bull rally. Year to date, the S&P Pharmaceuticals Select Industry index is down 1% while the benchmark S&P 500 index has gained 15%.
Merck to Hold Second-Quarter 2023 Sales and Earnings Conference Call on Aug. 1
06:45am, Thursday, 29'th Jun 2023
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Hold Second-Quarter 2023 Sales and Earnings Conference Call on Aug. 1.
Merck, Ridgeback withdraw COVID drug application in EU
08:49am, Tuesday, 27'th Jun 2023
Merck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union, months after the region's regulator did not back the drug c
Merck accused of downplaying early evidence of drug's brain impact
06:07am, Monday, 26'th Jun 2023
An early magazine advertisement for Merck's breakthrough asthma and allergy medicine, Singulair, featured a happy child, hanging upside-down from a tree. Asthmatic kids could now breathe easier, the t
Wall Street Says This Beaten-Down Stock May Climb Nearly 78%. Is That Too Optimistic?
05:30am, Saturday, 24'th Jun 2023
Moderna shares delivered enormous gains during the first year and a half of the pandemic. Since then, though, the stock has suffered as investors worry about declining revenues.
Dow Jones Today: Index Flat as Investors Mull Global Rate Decisions
05:10pm, Thursday, 22'nd Jun 2023
The Dow Jones Industrial Average closed down 0.01%, or 4 points, spending most of the day in the red as investors digested the latest moves by central banks around the world.
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
10:21am, Thursday, 22'nd Jun 2023
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Merck's (MRK) Gastric Cancer Study Fails to Meet a Primary Goal
11:49am, Wednesday, 21'st Jun 2023
Merck's (MRK) late-stage study evaluating Keytruda in advanced gastric cancer fails to meet one of the primary endpoints.
Merck's Keytruda fails to meet one main goal in gastric cancer trial
09:04am, Tuesday, 20'th Jun 2023
Merck & Co said on Tuesday its blockbuster immunotherapy Keytruda failed to meet one of the two main goals in a late-stage study testing it as a treatment option for a type of advanced gastric cancer.
Is Merck Stock a Top Buy Right Now?
09:15am, Monday, 19'th Jun 2023
Merck has been on a five year bull run, thanks to its superstar immuno-oncology medicine Keytruda. With this drug on track to lose market exclusivity in 2028, the company has been slowly building an i
Got $5,000? Buy These 2 Stocks and Hold Them Until Retirement
07:20am, Sunday, 18'th Jun 2023
The AI industry is still in its infancy, but Nvidia is already perfectly positioned to power its growth. Pharmaceutical outfit Merck is usually developing (or acquiring) more drug candidates than the
Merck: Approaching The Accumulation Phase With An Expanding Product Portfolio
01:57am, Saturday, 17'th Jun 2023
Keytruda sales totaled $5,795 million in Q1 2023, up 17% year-on-year, thanks partly to an increase in its indications for use. At the same time, Robert Davis does not actively use the share buyback p
How Has Merck Stock Performed During The 2022-23 Inflation Shock?
09:00am, Thursday, 15'th Jun 2023
Merck stock (NYSE: MRK) currently trades at $110 per share, roughly 43% above its level in March 2021, and it looks fully valued. Merck saw its stock trading.
